Market Currents
BioMimetic Therapeutics (BMTI +12.2%) soars a day after reporting positive data from a small...
-
Tuesday, February 7, 2012, 3:29 PM ETBioMimetic Therapeutics (BMTI +12.2%) soars a day after reporting positive data from a small trial testing its augment bone graft device in patients undergoing surgery for rotator cuff injuries. The FDA last month declined to approve the graft and sought more data, but the new information boosts hopes of attracting interest from potential partners.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
